Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.

Pfaller, M A; Boyken, L; Hollis, R J; Messer, S A; Tendolkar, S; Diekema, D J

Pfaller, M A; Boyken, L; Hollis, R J; Messer, S A; Tendolkar, S; Diekema, D J.

Affiliation

Pfaller MA; Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA. michael-pfaller@uiowa.edu

J Clin Microbiol ; 44(10): 3533-8, 2006 Oct.

Article in En | MEDLINE | ID: mdl-17021079

Subject(s)

Antifungal Agents/pharmacology; Candida/drug effects; Laboratories/standards; Lipoproteins/pharmacology; Peptides, Cyclic/pharmacology; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Candida / Laboratories / Lipoproteins / Antifungal Agents Type of study: Guideline / Screening_studies Language: En Journal: J Clin Microbiol Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google